We're now accepting manuscripts for the first annual Endocrine Practice Journal Symposium at the 2023 AACE Annual Meeting in Seattle, WA. The top three papers on the topic of diabetes and cardiovascular disease will be selected for presentation at the 2023 AACE Annual Meeting during a Journal Symposium at the 2023 AACE Annual Meeting, May 4 – 6, 2023, at the Washington State Convention Center in Seattle, Washington, US. Authors will give a 10-minute oral presentation followed by Q&A.
All other papers submitted for the journal symposium that are accepted will be published in a regular issue of Endocrine Practice.
Submission Deadline: October 31, 2022.
*Please note in manuscript cover letter that submission is for the 2023 Journal Symposium.
Clinical papers that focus on Cardiovascular and/or diabetes endpoints. Clinical trials encouraged and prioritized.
Cardiovascular and drugs for diabetes
- Safety and evolution of use
- Cardiometabolic and renal effects of hypoglycemic agents in patients with diabetes
- Meta analysis
Papers submitted will receive expedited peer review and all Article Processing Charges (APCs) will be waived. Papers accepted for publication but not chosen for the symposium will be published in next available issues of Endocrine Practice.
An author of the selected paper must attend the Endocrine Practice Journal Symposium at the AACE Annual Meeting. AACE cannot provide travel funding or honoraria.